Please provide your email address to receive an email when new articles are posted on . “The prednisone dosage in treatment of moderate to severe (myasthenia gravis [MG]) is commonly gradually ...

Credit: Getty Images. Avacopan plus rituximab offers a superior remission rate at 52 weeks and lower risk of relapse compared with prednisone taper plus rituximab, with a similar safety profile.

Avacopan and prednisone taper were associated with similar and substantial improvements in the control of active disease in multiple organ systems in the phase 3 ADVOCATE trial. Patients with ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...

In a single-center, single-arm, open-label pilot study, 30 adults (mean age, 73.7 years) with GCA received 162 mg of tocilizumab as a subcutaneous injection once a week for 52 weeks, plus prednisone ...

Credit: Getty images. Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion ...

Tapering doses of prednisone were administered in a blinded fashion at an initial dose of 15 mg per day for 2 weeks in the two groups to ensure adequate disease control at baseline (Table S1 in the ...

Gradual withdrawal of glucocorticoids was successful among patients with systemic lupus erythematosus (SLE) after 2 years of clinically quiescent disease, without an increased likelihood of flares, ...